Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Kalviainen, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 59 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kalviainen, R; Nousiainen, I
      Visual field defects with vigabatrin - Epidemiology and therapeutic implications

      CNS DRUGS
    2. Salmenpera, T; Kalviainen, R; Partanen, K; Pitkanen, A
      Hippocampal and amygdaloid damage in partial epilepsy - A cross-sectional MRI study of 241 patients

      EPILEPSY RESEARCH
    3. Kalviainen, R
      Monotherapy trial design: conversion versus de novo

      EPILEPSY RESEARCH
    4. Nousiainen, I; Mantyjarvi, M; Kalviainen, R
      No reversion in vigabatrin-associated visual field defects

      NEUROLOGY
    5. Kalviainen, R
      Long-term safety of tiagabine

      EPILEPSIA
    6. Lamusuo, S; Jutila, L; Ylinen, A; Kalviainen, R; Mervaala, E; Haaparanta, M; Jaaskelainen, S; Partanen, K; Vapalahti, M; Rinne, J
      [F-18]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage

      ARCHIVES OF NEUROLOGY
    7. Schmidt, D; Arroyo, S; Baulac, M; Dam, M; Dulac, O; Friis, ML; Kalviainen, R; Kramer, G; van Parys, J; Pedersen, B; Sachdeo, R
      Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view

      ACTA NEUROLOGICA SCANDINAVICA
    8. Nousiainen, I; Mantyjarvi, M; Kalviainen, R
      Visual function in patients treated with the GABAergic anticonvulsant drugtiagabine

      CLINICAL DRUG INVESTIGATION
    9. Salmenpera, T; Kalviainen, R; Partanen, K; Pitkanen, A
      Quantitative MRI volumetry of the entorhinal cortex in temporal lobe epilepsy

      SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
    10. Schmidt, D; Gram, L; Brodie, M; Kramer, G; Perucca, E; Kalviainen, R; Elger, CE
      Tiagabine in the treatment of epilepsy - a clinical review with a guide for the prescribing physician

      EPILEPSY RESEARCH
    11. Salmenpera, T; Kalviainen, R; Partanen, K; Mervaala, E; Pitkanen, A
      MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus

      EPILEPSY RESEARCH
    12. Nousiainen, I; Kalviainen, R; Mantyjarvi, M
      Color vision in epilepsy patients treated with vigabatrin or carbamazepinemonotherapy

      OPHTHALMOLOGY
    13. Lamusuo, S; Pitkanen, A; Jutila, L; Ylinen, A; Partanen, K; Kalviainen, R; Ruottinen, HM; Oikonen, V; Nagren, K; Lehikoinen, P; Vapalahti, M; Vainio, P; Rinne, JO
      [C-11]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy - Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology

      NEUROLOGY
    14. Nousiainen, I; Kalviainen, R; Mantyjarvi, M
      Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers

      BRITISH JOURNAL OF OPHTHALMOLOGY
    15. Aikia, M; Kalviainen, R; Mervaala, E; Riekkinen, PJ
      Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor

      EPILEPSY RESEARCH
    16. Kalviainen, R; Nousiainen, I; Mantyjarvi, M; Nikoskelainen, E; Partanen, J; Partanen, K; Riekkinen, P
      Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual fielddefects

      NEUROLOGY
    17. Kalviainen, R; Salmenpera, T; Partanen, K; Vainio, P; Riekkinen, P; Pitkanen, A
      Hippocampal damage and the onset of epilepsy - Reply

      NEUROLOGY
    18. Kalviainen, R
      Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy

      JOURNAL OF INTELLECTUAL DISABILITY RESEARCH
    19. PITKANEN A; TUUNANEN J; KALVIAINEN R; PARTANEN K; SALMENPERA T
      AMYGDALA DAMAGE IN EXPERIMENTAL AND HUMAN TEMPORAL-LOBE EPILEPSY

      Epilepsy research
    20. KALVIAINEN R; BRODIE MJ; DUNCAN J; CHADWICK D; EDWARDS D; LYBY K
      A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TIAGABINE GIVEN 3-TIMES DAILY AS ADD-ON THERAPY FOR REFRACTORY PARTIAL SEIZURES

      Epilepsy research
    21. Mikkonen, M; Soininen, H; Kalviainen, R; Tapiola, T; Ylinen, A; Vapalahti, M; Paljarvi, L; Pitkanen, A
      Remodeling of neuronal circuitries in human temporal lobe epilepsy: Increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex

      ANNALS OF NEUROLOGY
    22. SALMENPERA T; KALVIAINEN R
      HIPPOCAMPAL DAMAGE CAUSED BY SEIZURES IN TEMPORAL-LOBE EPILEPSY - REPLY

      Lancet
    23. SALMENPERA T; KALVIAINEN R; PARTANEN K; PITKANEN A
      HIPPOCAMPAL DAMAGE CAUSED BY SEIZURES IN TEMPORAL-LOBE EPILEPSY

      Lancet
    24. KALVIAINEN R; SALMENPERA T; PARTANEN K; VAINIO P; RIEKKINEN P; PITKANEN A
      RECURRENT SEIZURES MAY CAUSE HIPPOCAMPAL DAMAGE IN TEMPORAL-LOBE EPILEPSY

      Neurology
    25. KALVIAINEN R; PARTANEN K; AIKIA M; MANERMAA A; SALMENPERA T; RIEKKINEN PJ
      APOLIPOPROTEIN-E POLYMORPHISM IN RELATION TO HIPPOCAMPAL CELL-DAMAGE AND MEMORY IMPAIRMENT IN NEWLY-DIAGNOSED PARTIAL EPILEPSY

      Neurology
    26. RIEKKINEN P; KALVIAINEN R; SALMENPERA T; PERRY D; PEDERSEN PC
      TIAGABINE MONOTHERAPY IN CHRONIC PARTIAL EPILEPSY

      Neurology
    27. LAFRENIERE RG; ROCHEFORT DL; CHRETIEN N; ROMMENS JM; COCHIUS JI; KALVIAINEN R; NOUSIAINEN U; PATRY G; FARRELL K; SODERFELDT B; FEDERICO A; HALE BR; COSSIO OH; SORENSEN T; POULIOT MA; KMIEC T; ULDALL P; JANSZKY J; PRANZATELLI MR; ANDERMANN F; ANDERMANN E; ROULEAU GA
      UNSTABLE INSERTION IN THE 5'-FLANKING REGION OF THE CYSTATIN-B GENE IS THE MOST COMMON MUTATION IN PROGRESSIVE MYOCLONUS EPILEPSY TYPE-1, EPM1

      Nature genetics
    28. KALVIAINEN R; SALMENPERA T; PARTANEN K; VAINIO P; RIEKKINEN P; PITKANEN A
      MRI VOLUMETRY AND T2 RELAXOMETRY OF THE AMYGDALA IN NEWLY-DIAGNOSED AND CHRONIC TEMPORAL-LOBE EPILEPSY

      Epilepsy research
    29. AIKIA M; KALVIAINEN R; SALMENPERA T; RIEKKINEN PJ
      LONG-TERM COGNITIVE EFFECTS OF TIAGABINE

      Neurology
    30. SALMENPERA T; KALVIAINEN R; PARTANEN K; VAINIO P; RIEKKINEN PJ; PITKANEN A
      DO SEIZURES CAUSE NEURONAL DAMAGE - MRI VOLUMETRY AND T2 RELAXOMETRY OF THE HIPPOCAMPUS AND AMYGDALA IN TEMPORAL-LOBE EPILEPSY

      Neurology
    31. KALVIAINEN R; PARTANEN K; AIKIA M; MERVAALA E; VAINIO P; RIEKKINEN PJ; PITKANEN A
      MRI-BASED HIPPOCAMPAL VOLUMETRY AND T-2 RELAXOMETRY - CORRELATION TO VERBAL MEMORY PERFORMANCE IN NEWLY-DIAGNOSED EPILEPSY PATIENTS WITH LEFT-SIDED TEMPORAL-LOBE FOCUS

      Neurology
    32. LAMUSUO S; RUOTTINEN HM; KNUUTI J; HARKONEN R; RUOTSALAINEN U; BERGMAN J; HAAPARANTA M; SOLIN O; MERVAALA E; NOUSIAINEN U; JAASKELAINEN S; YLINEN A; KALVIAINEN R; RINNE JK; VAPALAHTI M; RINNE JO
      COMPARISON OF [F-18] FDG-PET, [TC-99M]-HMPAO-SPECT, AND [I-123] IOMAZENIL-SPECT IN LOCALIZING THE EPILEPTOGENIC CORTEX

      Journal of Neurology, Neurosurgery and Psychiatry
    33. KALVIAINEN R; AIKIA M; RIEKKINEN PJ
      COGNITIVE ADVERSE-EFFECTS OF ANTIEPILEPTIC DRUGS - INCIDENCE, MECHANISMS AND THERAPEUTIC IMPLICATIONS

      CNS DRUGS
    34. KALVIAINEN R; AIKIA M; MERVAALA E; SAUKKONEN AM; PITKANEN A; RIEKKINEN PJ
      LONG-TERM COGNITIVE AND EEG EFFECTS OF TIAGABINE IN DRUG-RESISTANT PARTIAL EPILEPSY

      Epilepsy research
    35. FISHER R; KALVIAINEN R; TANGANELLI P; REGESTA G
      NEWER ANTIEPILEPTIC DRUGS AS MONOTHERAPY - DATA ON VIGABATRIN

      Neurology
    36. PITKANEN A; LAAKSO M; KALVIAINEN R; PARTANEN K; VAINIO P; LEHTOVIRTA M; RIEKKINEN P; SOININEN H
      SEVERITY OF HIPPOCAMPAL ATROPHY CORRELATES WITH THE PROLONGATION OF MRI T-2 RELAXATION IN TEMPORAL-LOBE EPILEPSY BUT NOT IN ALZHEIMERS-DISEASE

      Neurology
    37. RIEKKINEN PJ; KALVIAINEN R; HALONEN T; PITKANEN A
      ASSOCIATION BETWEEN CEREBROSPINAL-FLUID GLUTAMATE LEVELS AND RESPONSETO INITIAL LONG-TERM RESPONSE TO VIGABATRIN MONOTHERAPY IN NEWLY-DIAGNOSED EPILEPSY

      Neurology
    38. KALVIAINEN R; PARTANEN K; AIKIA M; MERVAALA E; VAINIO P; RIEKKINEN PJ; PITKANEN A
      QUANTITATIVE MAGNETIC-RESONANCE-IMAGING IN NEWLY-DIAGNOSED EPILEPSY

      Neurology
    39. KALVIAINEN R; RIEKKINEN PJ
      VIGABATRIN AND CARBAMAZEPINE MONOTHERAPY FOR NEWLY-DIAGNOSED EPILEPSY- REPLY

      Archives of neurology
    40. AIKIA M; KALVIAINEN R; RIEKKINEN PJ
      VERBAL-LEARNING AND MEMORY IN NEWLY-DIAGNOSED PARTIAL EPILEPSY

      Epilepsy research
    41. AIKIA M; KALVIAINEN R; RIEKKINEN PJ
      VERBAL MEMORY PERFORMANCE AS EARLY PROGNOSTIC FACTOR IN NEWLY-DIAGNOSED EPILEPSY

      Neurology
    42. MERVAALA E; KOIVISTO K; HANNINEN T; PAAKKONEN A; KONONEN M; PARTANEN J; KALVIAINEN R; LAHTI T; RIEKKINEN P
      ELECTROPHYSIOLOGICAL AND NEUROPSYCHOLOGICAL PROFILES OF LAMOTRIGINE IN YOUNG AND AGE-ASSOCIATED MEMORY IMPAIRMENT (AAMI) SUBJECTS

      Neurology
    43. KALVIAINEN R; LAAKSO MP; PARTANEN K; SOININEN H; RIEKKINEN PJ; PITKANEN A
      ELEVATED MAGNETIC-RESONANCE T2 RELAXATION-TIME AS A MARKER OF HIPPOCAMPAL PATHOLOGY IN TEMPORAL-LOBE EPILEPSY - A COMPARISON TO ALZHEIMERS-DISEASE

      Neurology
    44. SALMENPERA T; KALVIAINEN R; RIEKKINEN PJ
      ECONOMIC-EVALUATION OF VIGABATRIN VERSUS CARBAMAZEPINE AS FIRST-LINE MONOTHERAPY

      Epilepsia
    45. MERVAALA E; PARTANEN J; PAAKKONEN A; KALVIAINEN R; YLINEN A; VAPALAHTI M
      NEW LOCALIZING EVIDENCE FROM INTRACRANIAL EVENT-RELATED POTENTIALS INEPILEPSY SURGERY

      Epilepsia
    46. KALVIAINEN R; AIKIA M; RIEKKINEN PJ
      VIGABATRIN MONOTHERAPY IN NEWLY-DIAGNOSED PATIENTS WITH EPILEPSY - 2-YEAR COMPARATIVE FOLLOW-UP OF EFFICACY, SAFETY, AND COGNITIVE EFFECTS

      Epilepsia
    47. KALVIAINEN R; AIKIA M; MERVAALA E; RIEKKINEN PJ
      LONG-TERM COGNITIVE EFFECTS OF TIAGABINE

      Epilepsia
    48. KALVIAINEN R; AIKIA M; SAUKKONEN AM; MERVAALA E; RIEKKINEN PJ
      VIGABATRIN VS CARBAMAZEPINE MONOTHERAPY IN PATIENTS WITH NEWLY-DIAGNOSED EPILEPSY - A RANDOMIZED, CONTROLLED-STUDY

      Archives of neurology
    49. YLINEN A; KALVIAINEN R; RIEKKINEN PJ
      LONG-TERM EFFICACY AND COGNITIVE EFFECTS OF VIGABATRIN

      Acta neurologica Scandinavica
    50. SAUKKONEN A; KALVIAINEN R; PARTANEN K; VAINIO P; RIEKKINEN P; PITKANEN A
      DO SEIZURES CAUSE NEURONAL DAMAGE - A MRI STUDY IN NEWLY-DIAGNOSED AND CHRONIC EPILEPSY

      NeuroReport
    51. VAINIO P; USENIUS JP; VAPALAHTI M; PARTANEN K; KALVIAINEN R; RINNE J; KAUPPINEN RA
      REDUCED N-ACETYLASPARTATE CONCENTRATION IN TEMPORAL-LOBE EPILEPSY BY QUANTITATIVE (1)HMRS IN-VIVO

      NeuroReport
    52. KUIKKA JT; MERVAALA E; VANNINEN E; KALVIAINEN R
      DOES TC-99M BICISATE IMAGE LOCAL BRAIN METABOLISM IN LATE ICTAL TEMPORAL-LOBE EPILEPSY

      European journal of nuclear medicine
    53. KALVIAINEN R; AIKIA M; MERVAALA E; SAUKKONEN AM; RIEKKINEN PJ
      PROGNOSIS OF NEWLY-DIAGNOSED EPILEPSY AND EFFECTS OF INITIAL VIGABATRIN MONOTHERAPY COMPARED WITH CARBAMAZEPINE MONOTHERAPY

      Neurology
    54. RIEKKINEN PJ; KALVIAINEN R; AIKIA M; MERVAALA E; SAUKKONEN AM; PITKANEN A
      COGNITIVE AND ELECTROPHYSIOLOGICAL EFFECTS OF TIAGABINE ADD-ON THERAPY - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

      Neurology
    55. COCHIUS J; CARPENTER S; ANDERMANN E; ROULEAU G; NOUSIAINEN U; KALVIAINEN R; FARRELL K; ANDERMANN F
      SWEAT GLAND VACUOLES IN UNVERRICHT-LUNDBORG DISEASE - A CLUE TO DIAGNOSIS

      Neurology
    56. SIVENIUS J; YLINEN A; KALVIAINEN R; RIEKKINEN PJ
      LONG-TERM STUDY WITH GABAPENTIN IN PATIENTS WITH DRUG-RESISTANT EPILEPTIC SEIZURES

      Archives of neurology
    57. COCHIUS JI; FIGLEWICZ DA; KALVIAINEN R; NOUSIAINEN U; FARRELL K; PATRY G; SODERFELDT B; FRYDMAN M; LERMAN P; ANDERMANN F; ANDERMANN E; ROULEAU GA
      UNVERRICHT-LUNDBORG DISEASE - ABSENCE OF NONALLELIC GENETIC-HETEROGENEITY

      Annals of neurology
    58. COCHIUS JI; FIGLEWICZ D; KALVIAINEN R; NOUSIAINEN U; FARRELL K; PATRY G; SODERFELDT B; ANDERMANN F; ANDERMANN E; ROULEAU GA
      UNVERRICHT-LUNDBORG DISEASE - ABSENCE OF NON-ALLELIC GENETIC-HETEROGENEITY

      Neurology
    59. KALVIAINEN R; KERANEN T; RIEKKINEN PJ
      PLACE OF NEWER ANTIEPILEPTIC DRUGS IN THE TREATMENT OF EPILEPSY

      Drugs


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 11:40:44